Analystreport

Xeris Biopharma (NASDAQ:XERS) was given a new $18.00 price target on by analysts at Oppenheimer Holdings, Inc..

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report